What Cancer Patients Should Know: Latest Immunotherapy News from ASCO

On June 1, 2015, at the 2015 annual meeting of the American Society of Clinical Oncology (ASCO) in Chicago, Jill O'Donnell-Tormey, PhD, Cancer Research Institute's CEO and director of scientific affairs, discussed the latest immunotherapy breakthroughs and what they mean for patients. Panelists were Jedd D. Wolchok, MD, PhD, and Jae Park, MD, both of Memorial Sloan Kettering Cancer Center, and Naiyer A. Rizvi, MD, of Columbia University Medical Center.

Learn the latest news in cancer immunotherapy for melanoma, lung cancer, leukemia, liver cancer, and other cancer types. For more information on immunotherapy, visit www.TheAnswerToCancer.org.


Join our email list for updates on cancer immunotherapy research, events, and opportunities to get involved with the Cancer Research Institute. Sign up below and be a force for change in the fight against cancer.

Join CRI in Shaping the Future of Immunotherapy

Support the pioneering work of CRI in advancing immunotherapy.

Father and son